These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome? La Marca A; Pati M; Giulini S; Levratti P; Caretto S; Volpe A Gynecol Endocrinol; 2005 Nov; 21(5):292-4. PubMed ID: 16373249 [TBL] [Abstract][Full Text] [Related]
8. Use of the GnRH agonist stimulation test in the diagnosis of ovarian remnant syndrome. A report of three cases. Scott RT; Beatse SN; Illions EH; Snyder RR J Reprod Med; 1995 Feb; 40(2):143-6. PubMed ID: 7738926 [TBL] [Abstract][Full Text] [Related]
9. [Adenocarcinoma of the ovary in the ovarian remnant syndrome]. Fueyo J; Garcés JM; Soriano JC; Coll J; Rubiés-Prat J Rev Clin Esp; 1990 May; 186(8):415-6. PubMed ID: 2236780 [No Abstract] [Full Text] [Related]
10. Serum LH and FSH levels in women with polycystic ovary syndrome before and after ovarian wedge resection. Shterev AD; Dokumov SI Endocrinologie; 1982; 20(3):203-7. PubMed ID: 6815773 [TBL] [Abstract][Full Text] [Related]
11. [Changes in the serum level of female sex hormones following radiocastration using different total doses]. Naujokat B; Rohloff R; Willich N; Eiermann W Strahlenther Onkol; 1988 Apr; 164(4):208-13. PubMed ID: 3129800 [TBL] [Abstract][Full Text] [Related]
12. Ovarian remnant syndrome. Webb MJ Aust N Z J Obstet Gynaecol; 1989 Nov; 29(4):433-5. PubMed ID: 2631678 [TBL] [Abstract][Full Text] [Related]
13. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial. Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878 [TBL] [Abstract][Full Text] [Related]
14. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325 [TBL] [Abstract][Full Text] [Related]
15. Laparoscopic management of ovarian remnant. Nezhat C; Kearney S; Malik S; Nezhat C; Nezhat F Fertil Steril; 2005 Apr; 83(4):973-8. PubMed ID: 15820809 [TBL] [Abstract][Full Text] [Related]
16. Ovarian remnant excision necessitating resection of the anterior hypogastric system. Unger JB; Paul RA Am J Obstet Gynecol; 2001 Jan; 184(2):235-6. PubMed ID: 11174511 [TBL] [Abstract][Full Text] [Related]
17. The ovarian remnant syndrome and ureteral obstruction: medical management. Koch MO; Coussens D; Burnett L J Urol; 1994 Jul; 152(1):158-60. PubMed ID: 8201651 [TBL] [Abstract][Full Text] [Related]
18. Clomiphene citrate stimulation as an adjunct in locating ovarian tissue in ovarian remnant syndrome. Kaminski PF; Sorosky JI; Mandell MJ; Broadstreet RP; Zaino RJ Obstet Gynecol; 1990 Nov; 76(5 Pt 2):924-6. PubMed ID: 2216258 [TBL] [Abstract][Full Text] [Related]